about
Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastomaCo-LncRNA: investigating the lncRNA combinatorial effects in GO annotations and KEGG pathways based on human RNA-Seq data.MTDH promotes glioma invasion through regulating miR-130b-ceRNAs.Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes.Genome-wide DNA methylome analysis reveals epigenetically dysregulated non-coding RNAs in human breast cancer.Construction and analysis of dynamic transcription factor regulatory networks in the progression of gliomaConstruction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer.LncRNA ontology: inferring lncRNA functions based on chromatin states and expression patterns.The mRNA related ceRNA-ceRNA landscape and significance across 20 major cancer types.Identifying and functionally characterizing tissue-specific and ubiquitously expressed human lncRNAsExtensive ceRNA-ceRNA interaction networks mediated by miRNAs regulate development in multiple rhesus tissues.Comprehensive analysis of the functional microRNA-mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression.Prioritizing candidate disease miRNAs by topological features in the miRNA target-dysregulated network: case study of prostate cancer.Identification of module biomarkers from the dysregulated ceRNA-ceRNA interaction network in lung adenocarcinoma.Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.Functional dissection of virus-human crosstalk mediated by miRNAs based on the VmiReg database.Disease-driven detection of differential inherited SNP modules from SNP networkIntegrating analysis reveals microRNA-mediated pathway crosstalk among Crohn's disease, ulcerative colitis and colorectal cancer
P50
Q28397795-0C67B04A-3A70-469C-A4D8-4F431A0935B5Q30993174-3A44C7EC-EAE2-43E0-A60C-0C61C2207C71Q33566650-CC9005CC-4758-4410-9504-D565EDA6EAC1Q34014258-F07A5545-2479-4192-8E0A-52506A82DABAQ34465725-3E2415E2-8A6D-475D-A99B-70F311AAB891Q36242231-030CAF21-AB17-469A-9120-67224E308FEFQ36413098-79EA1961-ACC5-4AB6-841D-E123A2D93948Q36545476-867A87C0-2DBE-4551-88EE-DD98BC324AF5Q36676632-83AB5B68-BBDD-46D0-83CC-F1C97C81C081Q36916431-7A11499A-C694-4F73-8459-63025E068A80Q37401115-2B3BB6E5-964E-4EB1-BE8D-B19724FC21EBQ37528839-AA8536D7-9D24-4F00-B5B3-12C55D420ADEQ38331384-40595445-ECF0-440F-8532-ADD83D9C99CAQ38458426-2BB827AF-F699-4990-A6C9-C353B1EFCF53Q38990723-73BB70FC-ED54-4D50-AD62-FB08CF5285E0Q41413228-CF0D5DB8-7905-4DDC-A492-8F7F139EB519Q84948194-71D9654E-8593-49BB-BDF8-5F187F278F92Q88120872-D4BB6106-1099-456A-B053-5E4284AAF494
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Juan Xu
@ast
Juan Xu
@en
Juan Xu
@es
Juan Xu
@nl
type
label
Juan Xu
@ast
Juan Xu
@en
Juan Xu
@es
Juan Xu
@nl
prefLabel
Juan Xu
@ast
Juan Xu
@en
Juan Xu
@es
Juan Xu
@nl
P106
P21
P31
P496
0000-0002-3709-4165